Prediction of 30-day mortality after surgery for infective endocarditis using risk scores: Insights from a European multicenter comparative validation study.

Cardiac surgery Early mortality EuroSCORE II Infective endocarditis Prediction Risk score

Journal

American heart journal
ISSN: 1097-6744
Titre abrégé: Am Heart J
Pays: United States
ID NLM: 0370465

Informations de publication

Date de publication:
05 Jun 2024
Historique:
received: 20 12 2023
revised: 30 05 2024
accepted: 31 05 2024
medline: 8 6 2024
pubmed: 8 6 2024
entrez: 7 6 2024
Statut: aheadofprint

Résumé

It remains unclear today whether risk scores created specifically to predict early mortality after cardiac operations for infective endocarditis (IE) outperform or not the European System for Cardiac Operative Risk Evaluation II (EuroSCORE II). Perioperative data and outcomes from a European multicenter series of patients undergoing surgery for definite IE were retrospectively reviewed. Only the cases with known pathogen and without missing values for all considered variables were retained for analyses. A comparative validation of EuroSCORE II and five specific risk scores for early mortality after surgery for IE - (1) STS-IE (Society of Thoracic Surgeons for IE); (2) PALSUSE (Prosthetic valve, Age ≥70, Large intra-cardiac destruction, Staphylococcus spp, Urgent surgery, Sex (female), EuroSCORE ≥10); (3) ANCLA (Anemia, New York Heart Association class IV, Critical state, Large intra-cardiac destruction, surgery on thoracic Aorta); (4) AEPEI II (Association pour l'Étude et la Prévention de l'Endocardite Infectieuse II); (5) APORTEI (Análisis de los factores PROnósticos en el Tratamiento quirúrgico de la Endocarditis Infecciosa) - was carried out using calibration plot and receiver-operating characteristic curve analysis. Areas under the curve (AUCs) were compared 1:1 according to the Hanley-McNeil's method. The agreement between APORTEI score and EuroSCORE II of the 30-day mortality prediction after surgery was also appraised. A total of 1,012 patients from five European university-affiliated centers underwent 1,036 cardiac operations, with a 30-day mortality after surgery of 9.7%. All IE-specific risk scores considered achieved better results than EuroSCORE II in terms of calibration; AEPEI II and APORTEI score showed the best performances. Despite poor calibration, EuroSCORE II overcame in discrimination every specific risk score (AUC, 0.751 vs. 0.693 or less, p=0.01 or less). For a higher/lesser than 20% expected mortality, the agreement of prediction between APORTEI score and EuroSCORE II was 86%. EuroSCORE II discrimination for 30-day mortality after surgery for IE was higher than five established IE-specific risk scores. AEPEI II and APORTEI score showed the best results in terms of calibration.

Sections du résumé

BACKGROUND BACKGROUND
It remains unclear today whether risk scores created specifically to predict early mortality after cardiac operations for infective endocarditis (IE) outperform or not the European System for Cardiac Operative Risk Evaluation II (EuroSCORE II).
METHODS METHODS
Perioperative data and outcomes from a European multicenter series of patients undergoing surgery for definite IE were retrospectively reviewed. Only the cases with known pathogen and without missing values for all considered variables were retained for analyses. A comparative validation of EuroSCORE II and five specific risk scores for early mortality after surgery for IE - (1) STS-IE (Society of Thoracic Surgeons for IE); (2) PALSUSE (Prosthetic valve, Age ≥70, Large intra-cardiac destruction, Staphylococcus spp, Urgent surgery, Sex (female), EuroSCORE ≥10); (3) ANCLA (Anemia, New York Heart Association class IV, Critical state, Large intra-cardiac destruction, surgery on thoracic Aorta); (4) AEPEI II (Association pour l'Étude et la Prévention de l'Endocardite Infectieuse II); (5) APORTEI (Análisis de los factores PROnósticos en el Tratamiento quirúrgico de la Endocarditis Infecciosa) - was carried out using calibration plot and receiver-operating characteristic curve analysis. Areas under the curve (AUCs) were compared 1:1 according to the Hanley-McNeil's method. The agreement between APORTEI score and EuroSCORE II of the 30-day mortality prediction after surgery was also appraised.
RESULTS RESULTS
A total of 1,012 patients from five European university-affiliated centers underwent 1,036 cardiac operations, with a 30-day mortality after surgery of 9.7%. All IE-specific risk scores considered achieved better results than EuroSCORE II in terms of calibration; AEPEI II and APORTEI score showed the best performances. Despite poor calibration, EuroSCORE II overcame in discrimination every specific risk score (AUC, 0.751 vs. 0.693 or less, p=0.01 or less). For a higher/lesser than 20% expected mortality, the agreement of prediction between APORTEI score and EuroSCORE II was 86%.
CONCLUSION CONCLUSIONS
EuroSCORE II discrimination for 30-day mortality after surgery for IE was higher than five established IE-specific risk scores. AEPEI II and APORTEI score showed the best results in terms of calibration.

Identifiants

pubmed: 38848985
pii: S0002-8703(24)00143-1
doi: 10.1016/j.ahj.2024.05.021
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest Dr. Giuseppe Gatti, Prof. Gianfranco Sinagra and Prof. Roberto Luzzati are three out of the ANCLA score creators. Dr. Giuseppe Gatti and Prof. Andrea Perrotti are two out of the AEPEI score I and II creators.

Auteurs

Giuseppe Gatti (G)

Cardio-Thoraco-Vascular Department, University of Trieste, Trieste, Italy. Electronic address: gius.gatti@gmail.com.

Antonio Fiore (A)

Department of Cardiac Surgery, Hôpitaux Universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France.

Maria Ismail (M)

Department of Thoracic and Cardio-Vascular Surgery, University Hospital Jean Minjoz and University of Franche-Comté, Besançon, France.

Andriy Dralov (A)

Department of Cardiac Surgery, Ospedale Santa Maria della Misericordia, Udine, Italy.

Wael Saade (W)

Department of Clinical, Internal Medicine, Anesthesiology and Cardiovascular Sciences, La Sapienza University, Rome, Italy.

Venera Costantino (V)

Microbiology Unit, Trieste University Hospital, Trieste, Italy.

Giulia Barbati (G)

Department of Medical Sciences, Biostatistics Unit, University of Trieste, Trieste, Italy.

Pascal Lim (P)

Department of Cardiology, Hôpitaux Universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris, Faculté de Santé, Université de Paris Est, Créteil, France.

Raphael Lepeule (R)

Unitée Transversale de Traitement des Infections, Hôpitaux Universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France.

Ilaria Franzese (I)

Cardio-Thoraco-Vascular Department, University of Trieste, Trieste, Italy.

Alessandro Minati (A)

Department of Clinical, Internal Medicine, Anesthesiology and Cardiovascular Sciences, La Sapienza University, Rome, Italy.

Sandro Sponga (S)

Department of Cardiac Surgery, Ospedale Santa Maria della Misericordia, Udine, Italy.

Enrico Fabris (E)

Cardio-Thoraco-Vascular Department, University of Trieste, Trieste, Italy.

Roberto Luzzati (R)

Department of Infective Diseases, University of Trieste, Trieste, Italy.

Gianfranco Sinagra (G)

Cardio-Thoraco-Vascular Department, University of Trieste, Trieste, Italy.

Giuseppe Biondi-Zoccai (G)

Department of Medical Surgical Sciences and Biotechnologies, La Sapienza University, Rome, Italy; Cardiology Unit, Santa Maria Goretti Hospital, Latina, Italy.

Giacomo Frati (G)

Department of Medical Surgical Sciences and Biotechnologies, La Sapienza University, Rome, Italy; Department of Angio-Cardio-Neurology, IRCCS Neuromed, Pozzilli, Italy.

Andrea Perrotti (A)

Department of Thoracic and Cardio-Vascular Surgery, University Hospital Jean Minjoz and University of Franche-Comté, Besançon, France.

Igor Vendramin (I)

Department of Cardiac Surgery, Ospedale Santa Maria della Misericordia, Udine, Italy.

Enzo Mazzaro (E)

Cardio-Thoraco-Vascular Department, University of Trieste, Trieste, Italy.

Classifications MeSH